Idexx Laboratories (IDXX) Operating Expenses (2009 - 2026)

Idexx Laboratories has reported Operating Expenses for 18 years, with the latest figure at $353.5 million in Q2 2026.

• On a quarterly basis, Operating Expenses rose 9.9% year-over-year to $353.5 million in Q2 2026; TTM through Jun 2026 was $1.4 billion, a 12.61% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 3.91% from the prior year.
• Operating Expenses was $353.5 million for Q2 2026 at Idexx Laboratories, down from $360.2 million in the prior quarter.
• The five-year high for Operating Expenses was $360.2 million in Q1 2026, with the low at $210.2 million in Q1 2022.
• Average Operating Expenses over 5 years is $278.7 million, with a median of $293.1 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Operating Expenses surged 54.37% in 2024, then fell 9.48% in 2025.
• Over 5 years, Operating Expenses stood at $215.0 million in 2022, then rose by 6.55% to $229.1 million in 2023, then soared by 34.89% to $309.0 million in 2024, then gained by 10.85% to $342.5 million in 2025, then advanced by 3.22% to $353.5 million in 2026.
• The last three Operating Expenses figures came in at $353.5 million (Q2 2026), $360.2 million (Q1 2026), and $342.5 million (Q4 2025), per Business Quant data.